Home » Analyst Articles – US
Precigen (NASDAQ:PGEN) Given New $10.00 Price Target at HC Wainwright
Precigen (NASDAQ:PGEN – Free Report) had its target price increased by HC Wainwright from $9.00 to $10.00 in a report published on Thursday,Benzinga reports. HC Wainwright currently has a buy rating on the biotechnology company’s... More of this article »
BMO Capital Markets Issues Positive Forecast for Navan (NASDAQ:NAVN) Stock Price
Navan (NASDAQ:NAVN – Free Report) had its price objective lifted by BMO Capital Markets from $13.00 to $15.00 in a report issued on Thursday,Benzinga reports. The firm currently has an outperform rating on the stock. A number... More of this article »
ARM’s (ARM) Overweight Rating Reaffirmed at Barclays
Barclays restated their overweight rating on shares of ARM (NASDAQ:ARM – Free Report) in a report released on Thursday,Benzinga reports. They currently have a $165.00 price objective on the stock. Other analysts have also issued... More of this article »
ARM (NASDAQ:ARM) Upgraded by Needham & Company LLC to “Buy” Rating
Needham & Company LLC upgraded shares of ARM (NASDAQ:ARM – Free Report) from a hold rating to a buy rating in a report issued on Thursday, MarketBeat reports. Needham & Company LLC currently has $200.00 target price... More of this article »
Navan (NASDAQ:NAVN) Price Target Cut to $18.00 by Analysts at Jefferies Financial Group
Navan (NASDAQ:NAVN – Free Report) had its target price reduced by Jefferies Financial Group from $20.00 to $18.00 in a report published on Thursday morning,Benzinga reports. They currently have a buy rating on the stock. A number... More of this article »
Navan (NASDAQ:NAVN) Price Target Lowered to $21.00 at Citigroup
Navan (NASDAQ:NAVN – Free Report) had its target price cut by Citigroup from $26.00 to $21.00 in a report issued on Thursday morning,Benzinga reports. They currently have a buy rating on the stock. Several other equities research... More of this article »
Navan (NASDAQ:NAVN) Given New $17.00 Price Target at Oppenheimer
Navan (NASDAQ:NAVN – Free Report) had its price objective cut by Oppenheimer from $25.00 to $17.00 in a report published on Thursday,Benzinga reports. They currently have an outperform rating on the stock. A number of other brokerages... More of this article »
Terns Pharmaceuticals (NASDAQ:TERN) Receives “Hold” Rating from TD Cowen
TD Cowen reaffirmed their hold rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a research report released on Thursday morning,Benzinga reports. TD Cowen currently has a $53.00 price objective on the... More of this article »
Terns Pharmaceuticals (NASDAQ:TERN) Receives Market Perform Rating from Citizens Jmp
Citizens Jmp reiterated their market perform rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Free Report) in a report released on Thursday,Benzinga reports. TERN has been the subject of a number of other research reports.... More of this article »
Beam Therapeutics (NASDAQ:BEAM) Price Target Raised to $68.00 at Citigroup
Beam Therapeutics (NASDAQ:BEAM – Free Report) had its price target increased by Citigroup from $64.00 to $68.00 in a research report sent to investors on Thursday,Benzinga reports. They currently have a buy rating on the stock. BEAM... More of this article »
Robinhood Markets (NASDAQ:HOOD) Price Target Cut to $91.00 by Analysts at The Goldman Sachs Group
Robinhood Markets (NASDAQ:HOOD – Free Report) had its target price cut by The Goldman Sachs Group from $102.00 to $91.00 in a research note issued to investors on Thursday morning,Benzinga reports. They currently have a buy rating... More of this article »
Stifel Nicolaus Issues Positive Forecast for Codere Online Luxembourg (NASDAQ:CDRO) Stock Price
Codere Online Luxembourg (NASDAQ:CDRO – Free Report) had its target price increased by Stifel Nicolaus from $8.50 to $9.00 in a research note released on Thursday morning,Benzinga reports. They currently have a hold rating on... More of this article »
Structure Therapeutics (NASDAQ:GPCR) Now Covered by Analysts at Wolfe Research
Wolfe Research began coverage on shares of Structure Therapeutics (NASDAQ:GPCR – Free Report) in a research note issued to investors on Thursday, MarketBeat Ratings reports. The brokerage issued a peer perform rating on the stock. Other... More of this article »
Robinhood Markets (NASDAQ:HOOD) Now Covered by Jefferies Financial Group
Jefferies Financial Group began coverage on shares of Robinhood Markets (NASDAQ:HOOD – Free Report) in a research report report published on Thursday, MarketBeat Ratings reports. The firm issued a buy rating and a $88.00 price... More of this article »
Gemini Space Station (NASDAQ:GEMI) Price Target Cut to $6.50 by Analysts at The Goldman Sachs Group
Gemini Space Station (NASDAQ:GEMI – Free Report) had its price target lowered by The Goldman Sachs Group from $7.50 to $6.50 in a research note released on Thursday,Benzinga reports. The brokerage currently has a neutral rating... More of this article »
Almonty Industries (NASDAQ:ALM) Receives “Buy” Rating from DA Davidson
DA Davidson restated their buy rating on shares of Almonty Industries (NASDAQ:ALM – Free Report) in a research report released on Thursday morning,Benzinga reports. The brokerage currently has a $25.00 price objective on the... More of this article »
Enphase Energy (NASDAQ:ENPH) Price Target Lowered to $54.00 at Jefferies Financial Group
Enphase Energy (NASDAQ:ENPH – Free Report) had its price target reduced by Jefferies Financial Group from $57.00 to $54.00 in a research report sent to investors on Thursday morning,Benzinga reports. Jefferies Financial Group... More of this article »
Royal Bank Of Canada Issues Positive Forecast for CSX (NASDAQ:CSX) Stock Price
CSX (NASDAQ:CSX – Free Report) had its price target hoisted by Royal Bank Of Canada from $39.00 to $43.00 in a research note published on Thursday morning,MarketScreener reports. They currently have an outperform rating on the... More of this article »
eToro Group (NASDAQ:ETOR) Given New $31.00 Price Target at The Goldman Sachs Group
eToro Group (NASDAQ:ETOR – Free Report) had its target price lowered by The Goldman Sachs Group from $35.00 to $31.00 in a research note issued to investors on Thursday,Benzinga reports. The Goldman Sachs Group currently has... More of this article »
Autodesk (NASDAQ:ADSK) Given New $456.00 Price Target at Arete Research
Autodesk (NASDAQ:ADSK – Free Report) had its price objective trimmed by Arete Research from $460.00 to $456.00 in a research report sent to investors on Thursday,MarketScreener reports. The firm currently has a buy rating on... More of this article »
Fractyl Health (NASDAQ:GUTS) Given Buy Rating at Canaccord Genuity Group
Canaccord Genuity Group restated their buy rating on shares of Fractyl Health (NASDAQ:GUTS – Free Report) in a research note released on Thursday morning,Benzinga reports. Canaccord Genuity Group currently has a $8.00 price... More of this article »
ASML (NASDAQ:ASML) Price Target Raised to $1,971.00 at Sanford C. Bernstein
ASML (NASDAQ:ASML – Free Report) had its price objective increased by Sanford C. Bernstein to $1,971.00 in a report issued on Thursday morning, MarketBeat reports. They currently have a buy rating on the semiconductor company’s... More of this article »
Coinbase Global (NASDAQ:COIN) Price Target Cut to $235.00 by Analysts at The Goldman Sachs Group
Coinbase Global (NASDAQ:COIN) had its price target cut by The Goldman Sachs Group from $270.00 to $235.00 in a research report sent to investors on Thursday, Marketbeat Ratings reports. They currently have a buy rating on the cryptocurrency... More of this article »
Northland Securities Issues Positive Forecast for Hallador Energy (NASDAQ:HNRG) Stock Price
Hallador Energy (NASDAQ:HNRG – Free Report) had its price objective upped by Northland Securities from $29.00 to $34.00 in a research report sent to investors on Thursday,Benzinga reports. Northland Securities currently has an... More of this article »
Enanta Pharmaceuticals (NASDAQ:ENTA) Now Covered by Rodman & Renshaw
Rodman & Renshaw initiated coverage on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a research report released on Thursday, MarketBeat.com reports. The firm issued a buy rating and a $20.00 target price... More of this article »
Comcast (NASDAQ:CMCSA) Price Target Cut to $26.00 by Analysts at BNP Paribas Exane
Comcast (NASDAQ:CMCSA – Free Report) had its price objective trimmed by BNP Paribas Exane from $27.00 to $26.00 in a research report sent to investors on Thursday,MarketScreener reports. The brokerage currently has an underperform... More of this article »
Casey’s General Stores (NASDAQ:CASY) Now Covered by JPMorgan Chase & Co.
JPMorgan Chase & Co. initiated coverage on shares of Casey’s General Stores (NASDAQ:CASY – Free Report) in a research note issued to investors on Thursday morning, MarketBeat.com reports. The brokerage issued a neutral... More of this article »
Figure Technology Solutions (NASDAQ:FIGR) Price Target Cut to $45.00 by Analysts at Mizuho
Figure Technology Solutions (NASDAQ:FIGR – Free Report) had its price target trimmed by Mizuho from $55.00 to $45.00 in a report issued on Thursday,Benzinga reports. The firm currently has an outperform rating on the stock. A... More of this article »
Brighthouse Financial’s (BHF) “Market Perform” Rating Reaffirmed at Keefe, Bruyette & Woods
Keefe, Bruyette & Woods reissued their market perform rating on shares of Brighthouse Financial (NASDAQ:BHF – Free Report) in a research note released on Thursday,Benzinga reports. The brokerage currently has a $67.00 price... More of this article »
Aligos Therapeutics (NASDAQ:ALGS) Now Covered by Analysts at Westpark Capital
Westpark Capital began coverage on shares of Aligos Therapeutics (NASDAQ:ALGS – Free Report) in a report issued on Thursday morning,Benzinga reports. The brokerage issued a buy rating and a $48.00 target price on the stock. Several... More of this article »
Exponent (NASDAQ:EXPO) Given New $95.00 Price Target at JPMorgan Chase & Co.
Exponent (NASDAQ:EXPO – Free Report) had its price objective cut by JPMorgan Chase & Co. from $100.00 to $95.00 in a research report sent to investors on Thursday morning,Benzinga reports. They currently have an overweight... More of this article »
Compass Pathways (NASDAQ:CMPS) Price Target Cut to $18.00 by Analysts at Canaccord Genuity Group
Compass Pathways (NASDAQ:CMPS – Free Report) had its price target decreased by Canaccord Genuity Group from $20.00 to $18.00 in a research report released on Thursday,Benzinga reports. Canaccord Genuity Group currently has a... More of this article »
Nexa Resources (NYSE:NEXA) Price Target Cut to $11.00 by Analysts at Citigroup
Nexa Resources (NYSE:NEXA – Free Report) had its price objective decreased by Citigroup from $13.00 to $11.00 in a research report sent to investors on Thursday morning,Benzinga reports. Citigroup currently has a neutral rating... More of this article »
Lincoln National (NYSE:LNC) Receives Outperform Rating from Keefe, Bruyette & Woods
Keefe, Bruyette & Woods reissued their outperform rating on shares of Lincoln National (NYSE:LNC – Free Report) in a research note released on Thursday,Benzinga reports. They currently have a $43.00 target price on the... More of this article »
CareTrust REIT (NYSE:CTRE) Price Target Raised to $42.00 at Wells Fargo & Company
CareTrust REIT (NYSE:CTRE – Free Report) had its target price raised by Wells Fargo & Company from $41.00 to $42.00 in a research note published on Thursday,Benzinga reports. The brokerage currently has an overweight rating... More of this article »
Globe Life’s (GL) Outperform Rating Reaffirmed at Keefe, Bruyette & Woods
Keefe, Bruyette & Woods reaffirmed their outperform rating on shares of Globe Life (NYSE:GL – Free Report) in a research report sent to investors on Thursday morning,Benzinga reports. The firm currently has a $168.00 target... More of this article »
FiscalNote (NYSE:NOTE) Given New $9.75 Price Target at LADENBURG THALM/SH SH
FiscalNote (NYSE:NOTE – Free Report) had its price target cut by LADENBURG THALM/SH SH from $11.00 to $9.75 in a report published on Thursday morning,Benzinga reports. They currently have a buy rating on the stock. Separately,... More of this article »
Genworth Financial (NYSE:GNW) Receives Outperform Rating from Keefe, Bruyette & Woods
Keefe, Bruyette & Woods reissued their outperform rating on shares of Genworth Financial (NYSE:GNW – Free Report) in a research note released on Thursday,Benzinga reports. The firm currently has a $10.50 price target on... More of this article »
Gartner (NYSE:IT) Given New $166.00 Price Target at UBS Group
Gartner (NYSE:IT – Free Report) had its target price lowered by UBS Group from $180.00 to $166.00 in a research note published on Thursday morning,Benzinga reports. The firm currently has a neutral rating on the information technology... More of this article »
Eversource Energy (NYSE:ES) Price Target Lowered to $70.00 at Mizuho
Eversource Energy (NYSE:ES – Free Report) had its price target trimmed by Mizuho from $75.00 to $70.00 in a report published on Thursday morning,Benzinga reports. The firm currently has a neutral rating on the utilities provider’s... More of this article »
Murphy USA (NYSE:MUSA) Now Covered by Analysts at JPMorgan Chase & Co.
JPMorgan Chase & Co. began coverage on shares of Murphy USA (NYSE:MUSA – Free Report) in a research note issued to investors on Thursday morning, MarketBeat Ratings reports. The brokerage issued an overweight rating and... More of this article »
HC Wainwright Issues Positive Forecast for Insmed (NASDAQ:INSM) Stock Price
Insmed (NASDAQ:INSM – Free Report) had its price objective increased by HC Wainwright from $230.00 to $245.00 in a report released on Thursday morning,Benzinga reports. They currently have a buy rating on the biopharmaceutical... More of this article »
DigitalOcean (NYSE:DOCN) Price Target Raised to $105.00 at Citizens Jmp
DigitalOcean (NYSE:DOCN – Free Report) had its price objective increased by Citizens Jmp from $83.00 to $105.00 in a research note issued to investors on Thursday morning,Benzinga reports. The firm currently has a market outperform... More of this article »
DiamondRock Hospitality (NYSE:DRH) Now Covered by LADENBURG THALM/SH SH
LADENBURG THALM/SH SH started coverage on shares of DiamondRock Hospitality (NYSE:DRH – Free Report) in a report issued on Thursday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $12.00 target price... More of this article »
Shift4 Payments (NYSE:FOUR) Downgraded by Raymond James Financial to “Outperform”
Raymond James Financial downgraded shares of Shift4 Payments (NYSE:FOUR – Free Report) from a strong-buy rating to an outperform rating in a report published on Thursday, MarketBeat Ratings reports. Raymond James Financial currently... More of this article »
KalVista Pharmaceuticals (NASDAQ:KALV) Given New $42.00 Price Target at Stifel Nicolaus
KalVista Pharmaceuticals (NASDAQ:KALV – Free Report) had its target price lifted by Stifel Nicolaus from $39.00 to $42.00 in a report released on Thursday morning,Benzinga reports. They currently have a buy rating on the specialty... More of this article »
Jefferies Financial Group (NYSE:JEF) Given New $47.00 Price Target at The Goldman Sachs Group
Jefferies Financial Group (NYSE:JEF – Free Report) had its price objective reduced by The Goldman Sachs Group from $54.00 to $47.00 in a research note issued to investors on Thursday morning,Benzinga reports. The Goldman Sachs... More of this article »
Novo Nordisk A/S (NYSE:NVO) Now Covered by Analysts at Wolfe Research
Wolfe Research started coverage on shares of Novo Nordisk A/S (NYSE:NVO – Free Report) in a report released on Thursday, Marketbeat.com reports. The brokerage issued a peer perform rating on the stock. NVO has been the topic... More of this article »